An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ank… (NCT02089425) | Clinical Trial Compass
TerminatedPhase 3
An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.
Stopped: Interim futility analysis
United States384 participantsStarted 2014-04
Plain-language summary
This is a randomized, double blind, placebo controlled, parallel group study to assess the efficacy and safety of K-103-IP compared with placebo patch for treatment of mild to moderate acute pain associated with ankle strain or sprain.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject must provide informed consent before any study specific evaluation is performed.
* Subject is male or female aged 18 to 70 years, inclusive.
* Subject has a grade 1 (mild functional impairment) or grade 2 (moderate functional impairment) ankle strain or sprain that occurred within 48 hours before the Screening visit.
* Subject has pain intensity upon monopodal weight bearing of 5 to 8, inclusive, measured by an 11 point nominal rating scale (NRS), plus pain intensity score at rest that is less than upon monopodal weight bearing.
Exclusion Criteria:
* Subject has a grade 3 (severe functional impairment) strain or sprain, bilateral strain or sprain, or concomitant fracture or wound at the site of the strain or sprain.
* Subject has had an ankle strain or sprain to the same foot within 6 months before the Screening visit.
* Subject has received topical analgesic medication within 24 hours before the Screening visit.
* Subject has applied ice or compression to the injured area within 2 hours before the Screening visit.